Stockholm, Sweden

Jarrko Kortesmaa

This inventor holds 1 USPTO granted patent. Top assignee: Biostratum, Inc.. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jarrko Kortesmaa: Innovator in Tissue Repair

Introduction

Jarrko Kortesmaa is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of tissue engineering and regenerative medicine. His work focuses on developing innovative solutions to enhance healing processes in vascular and mesenchymal tissues.

Latest Patents

Kortesmaa holds a patent for "Laminin 8 and methods for its use." This invention provides substantially purified laminin 8, methods for making recombinant laminin 8, and cells that express recombinant laminin 8. The patent outlines methods for using recombinant laminin 8 to accelerate the healing of injuries to vascular tissue and tissue of mesenchymal origin, as well as to promote cell attachment and migration.

Career Highlights

Throughout his career, Kortesmaa has been dedicated to advancing the understanding of tissue repair mechanisms. His innovative approaches have the potential to transform treatment protocols in regenerative medicine. He is currently associated with Biostratum, Inc., where he continues to work on groundbreaking research.

Collaborations

Kortesmaa collaborates with Karl Kristian Tryggvason, a fellow researcher in the field. Their partnership aims to further explore the applications of laminin 8 in medical treatments.

Conclusion

Jarrko Kortesmaa's contributions to the field of tissue engineering through his patent on laminin 8 highlight his commitment to improving healing processes. His work has the potential to significantly impact regenerative medicine and enhance patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…